Wells Fargo & Company Chroma Dex Corp. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Chroma Dex Corp. stock. As of the latest transaction made, Wells Fargo & Company holds 16,281 shares of CDXC stock, worth $89,708. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,281

Previous 16,876 3.53%

Holding current value

$89,708

Previous $46,000 28.26%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$2.51 - $3.8 $1,493 - $2,261	-595 Reduced 3.53%	16,281 $59,000
Q2 2024 Aug 13, 2024	BUY	$2.44 - $4.32 $37,256 - $65,962	15,269 Added 950.16%	16,876 $46,000
Q1 2024 May 10, 2024	BUY	$1.36 - $3.84 $9 - $26	7 Added 0.44%	1,607 $5,000
Q4 2023 Feb 09, 2024	BUY	$1.28 - $1.6 $26 - $33	21 Added 1.33%	1,600 $2,000
Q3 2023 Nov 13, 2023	SELL	$1.36 - $1.77 $21 - $28	-16 Reduced 1.0%	1,579 $2,000
Q2 2023 Aug 15, 2023	BUY	$1.31 - $1.79 $24 - $34	19 Added 1.21%	1,595 $2,000
Q1 2023 May 12, 2023	BUY	$1.48 - $2.19 $7 - $10	5 Added 0.32%	1,576 $2,000
Q4 2022 Feb 13, 2023	BUY	$1.25 - $1.94 $48 - $75	39 Added 2.55%	1,571 $2,000
Q3 2022 Nov 14, 2022	SELL	$1.19 - $2.06 $41 - $72	-35 Reduced 2.23%	1,532 $1,000
Q2 2022 Aug 12, 2022	SELL	$1.59 - $2.7 $129,662 - $220,182	-81,549 Reduced 98.11%	1,567 $3,000
Q1 2022 May 16, 2022	SELL	$2.02 - $3.92 $24,619 - $47,776	-12,188 Reduced 12.79%	83,116 $204,000
Q4 2021 Feb 14, 2022	BUY	$3.74 - $6.7 $62,166 - $111,367	16,622 Added 21.13%	95,304 $356,000
Q3 2021 Nov 15, 2021	BUY	$6.05 - $10.41 $279,086 - $480,213	46,130 Added 141.71%	78,682 $494,000
Q2 2021 Aug 16, 2021	SELL	$6.66 - $10.92 $720,132 - $1.18 Million	-108,128 Reduced 76.86%	32,552 $320,000
Q1 2021 May 13, 2021	BUY	$4.59 - $18.74 $152,709 - $623,479	33,270 Added 30.97%	140,680 $1.31 Million
Q4 2020 Feb 09, 2021	SELL	$3.93 - $5.5 $17,523 - $24,524	-4,459 Reduced 3.99%	107,410 $516,000
Q3 2020 Nov 05, 2020	BUY	$4.01 - $5.56 $33,158 - $45,975	8,269 Added 7.98%	111,869 $449,000
Q2 2020 Aug 13, 2020	BUY	$3.0 - $5.52 $80,514 - $148,145	26,838 Added 34.96%	103,600 $476,000
Q1 2020 May 14, 2020	BUY	$2.54 - $4.75 $194,975 - $364,619	76,762 New	76,762 $251,000

Others Institutions Holding CDXC

# of Institutions

Shares Held

17.2M

Call Options Held

66.7K

Put Options Held

8.2K

View Full List

About ChromaDex Corp.

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $377M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

More about CDXC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Chroma Dex Corp. Transaction History